1. ICH S7A: Safety Pharmacology studies for human pharmaceuticals;Anon;The European Agency for the Evaluation of Medicinal Products. Evaluation of Medicines for Human Use. CPMP/ICH/539/00,2000
2. ICH S7B: The non-clinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals. Step 2 Revision;Anon;US Food and Drug Administration, Department of Health and Human Services, Rockville, MD 20857-0001,2004
3. Clinical relevance of cardiac arrhythmias generated by afterdepolarizations. Role of M cells in the generation of U waves, triggered activity and torsade de pointes;Antzelevitch;J. Am. Coll. Cardiol.,1994
4. Measurement of bronchoconstriction using whole-body plethysmograph: comparison of freely moving versus restrained guinea pigs;Chong;J. Pharmacol. Tox. Meth.,1998
5. Loratadine blockade of K(+) channels in human heart: comparison with terfenadine under physiological conditions;Crumb;J. Pharmacol. Exp. Ther.,2000